3-[2-(4-FLUORO-PHENOXY)-ETHOXY]-PHENYLAMINE
![]() |
- $378 - $701
- Product name: 3-[2-(4-FLUORO-PHENOXY)-ETHOXY]-PHENYLAMINE
- CAS: 79808-17-6
- MF: C14H14FNO2
- MW: 247.26
- EINECS:
- MDL Number:MFCD08056103
- Synonyms:3-[2-(4-FLUORO-PHENOXY)-ETHOXY]-PHENYLAMINE;AKOS BC-2564;Benzenamine, 3-[2-(4-fluorophenoxy)ethoxy]-
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 5MG
- 1g
- 5g
- ManufacturerAK Scientific
- Product number9887AE
- Product description3-[2-(4-Fluoro-phenoxy)-ethoxy]-phenylamine
- Packaging1g
- Price$560
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0355744
- Product description3-[2-(4-FLUORO-PHENOXY)ETHOXY]PHENYLAMINE 95.00%
- Packaging5MG
- Price$495.58
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12030214
- Product description3-(2-(4-Fluorophenoxy)ethoxy)aniline 97%
- Packaging5g
- Price$701
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number020535
- Product description3-[2-(4-Fluoro-phenoxy)-ethoxy]-phenylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 9887AE | 3-[2-(4-Fluoro-phenoxy)-ethoxy]-phenylamine | 1g | $560 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0355744 | 3-[2-(4-FLUORO-PHENOXY)ETHOXY]PHENYLAMINE 95.00% | 5MG | $495.58 | 2021-12-16 | Buy |
Crysdot | CD12030214 | 3-(2-(4-Fluorophenoxy)ethoxy)aniline 97% | 5g | $701 | 2021-12-16 | Buy |
Matrix Scientific | 020535 | 3-[2-(4-Fluoro-phenoxy)-ethoxy]-phenylamine | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :418.6±30.0 °C(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.21±0.10(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.21±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|